San Francisco, 21 November
2018: According to a report by Grand View Research, Inc.; the global
cancerstem cells market is anticipated to attain a valuation of around USD
1.6 billion by 2025. Growing requirement for advanced cancer therapeutics is projected
to propel market over the forecast period (2014 to 2028). Cancer stem cells are
utilized for immune-constitution and replenishment of blood after tumor
development or treatment. In addition, they are expected to gain significant
traction among healthcare entities for delivery of anti-cancer agents and for
tissue regeneration. This factor is expected to bode well for demand in near
future.
Increasing R&D for
development of novel and effective treatment methods based on stem cells are projected
to positively influence growth of the market for cancer stem cells. Continual
improvements in experimental approaches are expected to enable scientists to
establish relationship between different cell types in tumor and their
microenvironment. This factor is anticipated to further augment market. High
prevalence of cancer and demand for effective treatments can stimulate market
growth during the forecast period.
The worldwide cancer stem
cells market can be segregated on the basis of mode of action, cancer forms,
and region. Based on mode of action, the market can be categorized into
targeted Cancerous Stem Cells (CSCs) and stem cells based cancer therapy.
Targeted CSCs use recombinant proteins, monoclonal antibodies, nanomaterials,
and other natural compounds. Majority of commercially available drugs facilitate
tumor shrinkage. However, they do not target root cause of tumor progression,
which can result in relapse of tumor growth. Such factors are likely to boost
growth of this segment. In addition, increasing research activities in CSCs
biology and key signaling pathways, surface markers, and microenvironment are
likely to enable development of agents that target these aspects of CSCs to
control their regulation.
Access
Research Report of Cancer
Stem Cells Market@ www.grandviewresearch.com/industry-analysis/cancer-stem-cells-market
On the other hand, stem cells are
used for tissue regeneration, delivery of anti-cancer therapeutics, and for immuno-reconstitution.
This segment can be bifurcated further into allogenic cell treatment and
autologous treatment. Autologous treatment segment dominated the market and
accounted for the largest market share in 2016. Factors such as improved
survival rate and affordability are estimated to fuel demand over the forecast
period.
Based on cancer forms, the
market for cancer stem cells can be classified into breast, blood, lung, brain,
bladder, liver, pancreatic, colorectal, and other types of cancer. In 2016,
breast cancer dominated with the largest market share. Rising cases of breast
cancer coupled with presence of large number of stem cell therapies were the
primary driving factors. In addition, growing adoption of autologous transplant
driving influence of chemotherapy to next level is anticipated to stimulate
growth over the forecast period. Moreover, ability of these therapies to
successfully combat cardiotoxicity observed in survivors is projected to give a
fillip to market growth. Lung cancer is anticipated to witness significant
growth in terms of demand. Ongoing developments to curb prevalence of lung
malignance may boost the expansion in near future.
Browse more reports of this category by
Grand View Research at: www.grandviewresearch.com/industry/biotechnology
Regional segmentation includes
Europe, North America, Asia Pacific, Latin America, and Middle East and Africa.
In 2016, North America held the largest market share. Presence of significant
number of organizations and rising R&D activities related to stem cell
therapy are some of the major regional growth drivers. In addition, strong
presence of internationally recognized medical institutes and hospitals offering
stem cell transplant therapies is projected to create growth opportunities for
the market in the forthcoming years. Asia Pacific is estimated to grow well
over the forecast period owing to presence of numerous organizations focusing
on R&D of stem cells. In addition, rise in funding and grants for research
communities to boost scientific research can fuel regional market.
Some of the leading companies operating in the global cancer
stem cells market are Thermo Fisher Scientific, Inc.; AbbVie, Inc.; Merck KGaA;
Bionomics; and PromoCell GmbH. Most companies are adopting innovation and
business collaborations among other business strategies to stay competitive.
Growing popularity of stem cell therapy in clinical oncology can push these
companies to follow advanced strategies such as broadening product pipeline and
facility expansion.
Access
Press Release of Cancer Stem Cells Market@ www.grandviewresearch.com/press-release/global-cancer-stem-cells-market
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For More
Information: www.grandviewresearch.com
No comments:
Post a Comment